1. Academic Validation
  2. The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA

The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA

  • J Biol Chem. 2009 May 15;284(20):13881-13891. doi: 10.1074/jbc.M900818200.
Xiaojun Li 1 C T Ranjith-Kumar 2 Monica T Brooks 3 S Dharmaiah 2 Andrew B Herr 3 Cheng Kao 2 Pingwei Li 4
Affiliations

Affiliations

  • 1 Department of Biochemistry and Biophysics, Texas A & M University, College Station, Texas 77843-2128.
  • 2 Department of Biology and the Multidisciplinary Biochemistry Program, Indiana University, Bloomington, Indiana 47405.
  • 3 Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0524.
  • 4 Department of Biochemistry and Biophysics, Texas A & M University, College Station, Texas 77843-2128. Electronic address: [email protected].
Abstract

The RIG-I-like receptors (RLRs), RIG-I and MDA5, recognize single-stranded RNA with 5' triphosphates and double-stranded RNA (dsRNA) to initiate innate Antiviral immune responses. LGP2, a homolog of RIG-I and MDA5 that lacks signaling capability, regulates the signaling of the RLRs. To establish the structural basis of dsRNA recognition by the RLRs, we have determined the 2.0-A resolution crystal structure of human LGP2 C-terminal domain bound to an 8-bp dsRNA. Two LGP2 C-terminal domain molecules bind to the termini of dsRNA with minimal contacts between the protein molecules. Gel filtration chromatography and analytical ultracentrifugation demonstrated that LGP2 binds blunt-ended dsRNA of different lengths, forming complexes with 2:1 stoichiometry. dsRNA with protruding termini bind LGP2 and RIG-I weakly and do not stimulate the activation of RIG-I efficiently in cells. Surprisingly, full-length LGP2 containing mutations that abolish dsRNA binding retained the ability to inhibit RIG-I signaling.

Figures